Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin.

Ciprofloxacin (CIP) is a poorly soluble drug that also displays poor permeability. Attempts to improve the solubility of this drug to date have largely focused on the formation of crystalline salts and metal complexes. The aim of this study was to prepare amorphous solid dispersions (ASDs) by ball milling CIP with various polymers. Following examination of their solid state characteristics and physical stability, the solubility advantage of these ASDs was studied, and their permeability was investigated via parallel artificial membrane permeability assay (PAMPA). Finally, the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the ASDs were compared to those of CIP. It was discovered that acidic polymers, such as Eudragit L100, Eudragit L100-55, Carbopol, and HPMCAS, were necessary for the amorphization of CIP. In each case, the positively charged secondary amine of CIP was found to interact with carboxylate groups in the polymers, forming amorphous polymeric drug salts. Although the ASDs began to crystallize within days under accelerated stability conditions, they remained fully X-ray amorphous following exposure to 90% RH at 25 °C, and demonstrated higher than predicted glass transition temperatures. The solubility of CIP in water and simulated intestinal fluid was also increased by all of the ASDs studied. Unlike a number of other solubility enhancing formulations, the ASDs did not decrease the permeability of the drug. Similarly, no decrease in antibiotic efficacy was observed, and significant improvements in the MIC and MBC of CIP were obtained with ASDs containing HPMCAS-LG and HPMCAS-MG. Therefore, ASDs may be a viable alternative for formulating CIP with improved solubility, bioavailability, and antimicrobial activity.

[1]  P. Saulnier,et al.  Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  H. Mesallati,et al.  Two Faces of Ciprofloxacin: Investigation of Proton Transfer in Solid State Transformations , 2016 .

[3]  G. Balogh,et al.  Investigation and Mathematical Description of the Real Driving Force of Passive Transport of Drug Molecules from Supersaturated Solutions. , 2016, Molecular pharmaceutics.

[4]  A. Dahan,et al.  Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility-Permeability Interplay. , 2015, Journal of pharmaceutical sciences.

[5]  J. Lubach,et al.  Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy. , 2015, Molecular pharmaceutics.

[6]  I. Marrucho,et al.  Novel organic salts based on fluoroquinolone drugs: synthesis, bioavailability and toxicological profiles. , 2014, International journal of pharmaceutics.

[7]  T. Rades,et al.  Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline , 2014, Pharmaceutics.

[8]  Bradley D Anderson,et al.  Molecular dynamics simulation of amorphous hydroxypropyl-methylcellulose acetate succinate (HPMCAS): polymer model development, water distribution, and plasticization. , 2014, Molecular pharmaceutics.

[9]  S. Qi,et al.  Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling. , 2014, Molecular pharmaceutics.

[10]  Wei-guo Dai,et al.  Fundamental aspects of solid dispersion technology for poorly soluble drugs , 2013, Acta pharmaceutica Sinica. B.

[11]  A. Healy,et al.  Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid. , 2013, Molecular pharmaceutics.

[12]  P. Kan,et al.  Spray dried inhalable ciprofloxacin powder with improved aerosolisation and antimicrobial activity. , 2013, International journal of pharmaceutics.

[13]  Christel A. S. Bergström,et al.  Optimizing solubility and permeability of a biopharmaceutics classification system (BCS) class 4 antibiotic drug using lipophilic fragments disturbing the crystal lattice. , 2013, Journal of medicinal chemistry.

[14]  M. Maniruzzaman,et al.  Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions. , 2013, International journal of pharmaceutics.

[15]  I. Vattulainen,et al.  Mechanism for translocation of fluoroquinolones across lipid membranes. , 2012, Biochimica et biophysica acta.

[16]  Arik Dahan,et al.  A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability. , 2012, Molecular pharmaceutics.

[17]  Wean Sin Cheow,et al.  Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility. , 2012, Journal of colloid and interface science.

[18]  A. Falcão,et al.  Optimization of a parallel artificial membrane permeability assay for the fast and simultaneous prediction of human intestinal absorption and plasma protein binding of drug candidates: application to dibenz[b,f]azepine-5-carboxamide derivatives. , 2012, Journal of pharmaceutical sciences.

[19]  Sérgio M. Santos,et al.  Packing interactions in hydrated and anhydrous forms of the antibiotic Ciprofloxacin: a solid-state NMR, X-ray diffraction, and computer simulation study. , 2012, Journal of the American Chemical Society.

[20]  O. Čudina,et al.  A PAMPA Assay as Fast Predictive Model of Passive Human Skin Permeability of New Synthesized Corticosteroid C-21 Esters , 2012, Molecules.

[21]  J. Parojčić,et al.  Biopharmaceutical characterization of ciprofloxacin HCl-ferrous sulfate interaction. , 2011, Journal of pharmaceutical sciences.

[22]  K. A. Kumar,et al.  Fluoroquinolone salts with carboxylic acids. , 2011, Journal of pharmaceutical sciences.

[23]  Dallas B. Warren,et al.  Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility , 2010, Journal of drug targeting.

[24]  Cong Zhang,et al.  Thermodynamics of the solubility of ciprofloxacin in methanol, ethanol, 1-propanol, acetone, and chloroform from 293.15 to 333.15K , 2010 .

[25]  N. M. Zaki,et al.  A modified physiological BCS for prediction of intestinal absorption in drug discovery. , 2010, Molecular pharmaceutics.

[26]  Jiao Yang,et al.  An improved kinetics approach to describe the physical stability of amorphous solid dispersions. , 2010, International journal of pharmaceutics.

[27]  A. Avdeef,et al.  The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability. , 2010, Journal of medicinal chemistry.

[28]  G. Buckton,et al.  Evaluation of Griseofulvin Binary and Ternary Solid Dispersions with HPMCAS , 2009, AAPS PharmSciTech.

[29]  R. Manzo,et al.  Characterization of the solubility and solid-state properties of saccharin salts of fluoroquinolones. , 2009, Journal of pharmaceutical sciences.

[30]  R. Manzo,et al.  Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives. , 2009, International journal of pharmaceutics.

[31]  D. T. Friesen,et al.  Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. , 2008, Molecular pharmaceutics.

[32]  W. Brostow,et al.  Prediction of glass transition temperatures: Binary blends and copolymers , 2008 .

[33]  O. Almarsson,et al.  Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. , 2007, Journal of pharmaceutical sciences.

[34]  A. Bansal,et al.  A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  Abu T M Serajuddin,et al.  Salt formation to improve drug solubility. , 2007, Advanced drug delivery reviews.

[36]  James S. Taylor,et al.  Ideal copolymers and the second‐order transitions of synthetic rubbers. i. non‐crystalline copolymers , 2007 .

[37]  V. Caron,et al.  Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g). , 2007, Journal of pharmaceutical sciences.

[38]  Yiqiao Hu,et al.  Investigation of excipient and processing on solid phase transformation and dissolution of ciprofloxacin. , 2007, International journal of pharmaceutics.

[39]  I. Tamai,et al.  Identification of influx transporter for the quinolone antibacterial agent levofloxacin. , 2007, Molecular pharmaceutics.

[40]  Lynne S Taylor,et al.  Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. , 2006, Journal of pharmaceutical sciences.

[41]  Alfred H. Schinkel,et al.  BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2) TRANSPORTS FLUOROQUINOLONE ANTIBIOTICS AND AFFECTS THEIR ORAL AVAILABILITY, PHARMACOKINETICS, AND MILK SECRETION , 2006, Drug Metabolism and Disposition.

[42]  H W Frijlink,et al.  Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. , 2006, International journal of pharmaceutics.

[43]  M. Bermejo,et al.  Mathematical modelling of in situ and in vitro efflux of ciprofloxacin and grepafloxacin. , 2006, International journal of pharmaceutics.

[44]  G. Verreck,et al.  Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[45]  V. L. Dorofeev.  The betainelike structure and infrared spectra of drugs of the fluoroquinolone group , 2004, Pharmaceutical Chemistry Journal.

[46]  L. Sabath,et al.  Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  Marival Bermejo,et al.  PAMPA--a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[48]  Yuichi Nishiyama,et al.  Evaluation of Hypromellose Acetate Succinate (HPMCAS) as a Carrier in Solid Dispersions , 2004, Drug development and industrial pharmacy.

[49]  Lynne S. Taylor,et al.  Influence of Alkali Metal Counterions on the Glass Transition Temperature of Amorphous Indomethacin Salts , 2002, Pharmaceutical Research.

[50]  G. Zografi,et al.  The Effects of Absorbed Water on the Properties of Amorphous Mixtures Containing Sucrose , 1999, Pharmaceutical Research.

[51]  G. Zografi,et al.  Phase Behavior of Binary and Ternary Amorphous Mixtures Containing Indomethacin, Citric Acid, and PVP , 1998, Pharmaceutical Research.

[52]  Alex Avdeef,et al.  Absorption and Drug Development: Solubility, Permeability, and Charge State , 2003 .

[53]  K. Morimoto,et al.  Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[54]  L Yu,et al.  Amorphous pharmaceutical solids: preparation, characterization and stabilization. , 2001, Advanced drug delivery reviews.

[55]  B. Faller,et al.  High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.

[56]  F. Sörgel,et al.  Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose. , 1999, International journal of antimicrobial agents.

[57]  G. Zografi,et al.  Effects of sorbed water on the crystallization of indomethacin from the amorphous state. , 1997, Journal of pharmaceutical sciences.

[58]  Stephen R. Byrn,et al.  A novel class of phenol–pyridine co-crystals for secondharmonic generation , 1997 .

[59]  U. Fuhr,et al.  Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule. , 1990, British journal of clinical pharmacology.

[60]  Alexander T. Florence,et al.  Physicochemical Principles of Pharmacy , 1988 .

[61]  G. Drusano,et al.  Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers , 1987, Antimicrobial Agents and Chemotherapy.

[62]  M. Lucas,et al.  Intestinal surface acid microclimate in vitro and in vivo in the rat. , 1986, The Journal of laboratory and clinical medicine.

[63]  H. Neu,et al.  Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks , 1985, Journal of clinical microbiology.

[64]  L. Ayers,et al.  Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid , 1984, Antimicrobial Agents and Chemotherapy.

[65]  G. Flynn,et al.  Solubility of organic hydrochlorides. , 1972, Journal of pharmaceutical sciences.

[66]  G. S. Banker,et al.  Polymer-drug interacted systems in the physicochemical design of pharmaceutical dosage forms. I. Drug salts with PVM-MA and with a PVM-MA hemi-ester. , 1968, Journal of pharmaceutical sciences.